Over 60 Years Of Litigation Experience

New drug boosts immune response in mesothelioma patients

Mesothelioma is an aggressive cancer that causes serious medical and financial issues for the people who eventually develop it. Workplace and environmental exposure to asbestos can cause mesothelioma, but people often don’t realize the issue right away.

Although mesothelioma is aggressive once it begins to present symptoms and often progresses quite quickly, the initial onset of the cancer often takes decades. Quite a few people end up becoming ill 20 years or more after their dangerous asbestos exposure. That delay means that those dealing with mesothelioma could be in the later stages of life and dealing with declines in health and their immune system that come with it.

Currently, there are no medications that can cure mesothelioma, but there are certain options available that can slow its spread and reduce the experience of painful and unpleasant symptoms by those with this cancer. A new drug may represent a real light of hope for those struggling after a mesothelioma diagnosis.

ONCOS-102, potentially with other drugs, can boost the immune system

Immunotherapy drugs are some of the most exciting new developments in the world of fighting cancer and tumors. Most traditional cancer drugs work by attacking rapidly-dividing cells. That means that people experience an overall decline in health and a dramatic loss of body hair while in chemotherapy or radiation treatment.

Immunotherapy medications, on the other hand, help the body increase its response to the influx of cancerous cells. In some cases, the medications can even help the body target specific kinds of cells. ONCOS-102, formerly known as CGTG-102, has been the subject of multiple medical studies in recent years. In addition to showing great promise for treating solid tumors, ONCOS-102 could also potentially help those dealing with mesothelioma.

Who pays for new treatments or medical study participation?

When a medicine reaches the market, insurance carriers have to look carefully at the research for that drug, the potential impact it has, how it compares with other medications and its cost. All of those factors influence whether the company will cover that drug if prescribed and how much they expect patients to pay out of pocket.

Many new drugs only have minimal coverage, while some may not be available through insurance at all. Medical studies sometimes pay participants or offer them free care and hospitalization. Other times, participants must cover a portion of their medical costs incurred during the study. Covering those expenses while dealing with the consequences of a serious cancer like mesothelioma may prove too difficult for many people to manage.

Compensation through a mass tort or class action lawsuit against a company that hired you and that exposed you to asbestos — or a claim against a bankruptcy fund that’s in place for those who developed mesothelioma — could help you cover the costs of care and improve your quality of life while undergoing treatment.